Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wound Catheter Study
ChiCTR-TRC-14004890Phase 4Not yet recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Morphine consumption during the first 72 hours after surgery. Planned start Aug 2014; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR-TRC-14004890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004890.